Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells.

Peyvandi, Sanam

Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells. [electronic resource] - Cancer research Oct 2015 - 4292-301 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1538-7445

10.1158/0008-5472.CAN-14-1848 doi


Animals
Antigens, Surface--metabolism
B7-H1 Antigen--metabolism
Biomarkers
Bone Marrow Cells--immunology
Cell Line, Tumor
Disease Models, Animal
Fas Ligand Protein--deficiency
Humans
Immunomodulation
Immunophenotyping
Macrophages--immunology
Mice
Mice, Knockout
Myeloid Cells--immunology
Neoplasms--genetics
Programmed Cell Death 1 Receptor--metabolism
Signal Transduction
T-Lymphocyte Subsets--immunology
T-Lymphocytes, Regulatory--immunology
Tumor Burden--genetics
Tumor Microenvironment--immunology